UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000003990
Receipt No. R000004805
Scientific Title A Phase I /II Study of Bi-weekly XELIRI with Bevacizumab for patient with Metastatic Colorectal Cancer as second-line chemotherapy.
Date of disclosure of the study information 2010/08/25
Last modified on 2016/02/16 10:52:00

No. Disposal Last modified on Item of update
1 Insert 2010/08/03 19:47:51
2 Update 2010/08/04 16:04:41 Acronym
Acronym
3 Update 2014/05/26 12:35:31 Recruitment status
4 Update 2014/11/09 14:01:54 Key exclusion criteria
5 Update 2014/11/09 14:02:19 Email
Email
Post marketing survey by drug manufacture etc., specified by Japanese law.
6 Update 2016/02/16 10:52:00 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results


Contact us.